Shanghai MicroPort CardioFlow Medtech Co., Ltd. (hereafter referred to as MicroPort CardioFlow) was established in 2015, located in Zhangjiang High-Tech Park, Shanghai, it’s one of the holding subsidiaries of MicroPort Group. MicroPort CardioFlow is dedicated in providing advanced minimally invasive therapies for structural heart diseases, with best-in-class R&D, manufacturing, marketing, and technical consulting capacities.